Table 2.
Distribution of the classes of anti-hypertensive drugs in the initial visit (V1) and final visit (Vf). Goiânia – GO
| V1 | Vf | p | |
|---|---|---|---|
| Diuretic | 53.5% (38) | 60.6% (43) | 0.511 |
| ACEI | 22.5% (16) | 46.5% (33) | 0.004 |
| ARB | 4.2% (3) | 35.2% (25) | <0.001 |
| CCB | 18.3% (13) | 67.6% (48) | <0.001 |
| BB | 16.9% (12) | 16.9% (12) | - |
| Spironolactone | 0 | 5.63% (4) | 0.125 |
| Others | 29.6% (21) | 16.9% (12) | 0.078 |
McNemar test; significant: p<0.05; values expressed as percentage and absolute numbers; ACEI: angiotensin-converting-enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium-channel blocker; BB: beta-blocker.